Claritine

Medicinal product

(Invented) name

Claritine

Active substance (s)

Loratadinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX13, Loratadine

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2020-12-14

Date of renewal

Documents

1439_Claritine_2023-08-11_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Loratadinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105424	91524	1091524	lizdinė plokštelė	N30		Receptinis	LT/L/20/1439/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-12-14	Registruotas